These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 32307319)

  • 1. Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low-and middle-income countries.
    Kretchy IA; Asiedu-Danso M; Kretchy JP
    Res Social Adm Pharm; 2021 Jan; 17(1):2023-2026. PubMed ID: 32307319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of COVID-19 on access to healthcare in low- and middle-income countries: Current evidence and future recommendations.
    Okereke M; Ukor NA; Adebisi YA; Ogunkola IO; Favour Iyagbaye E; Adiela Owhor G; Lucero-Prisno DE
    Int J Health Plann Manage; 2021 Jan; 36(1):13-17. PubMed ID: 32857892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community Pharmacists: On the frontline of health service against COVID-19 in LMICs.
    Hedima EW; Adeyemi MS; Ikunaiye NY
    Res Social Adm Pharm; 2021 Jan; 17(1):1964-1966. PubMed ID: 32317154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of an interprofessional medication adherence program for chronic patients in community pharmacies: how much does it cost for the provider?
    Perraudin C; Locca JF; Rossier C; Bugnon O; Schneider MP
    BMC Health Serv Res; 2019 Jan; 19(1):15. PubMed ID: 30621697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 pandemic: The role of community pharmacists in chronic kidney disease management supportive care.
    Okoro RN
    Res Social Adm Pharm; 2021 Jan; 17(1):1925-1928. PubMed ID: 33317766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of community pharmacists in medication management during COVID-19 lockdown.
    Akour A; Elayeh E; Tubeileh R; Hammad A; Ya'Acoub R; Al-Tammemi AB
    Pathog Glob Health; 2021 May; 115(3):168-177. PubMed ID: 33573528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient satisfaction with pharmaceutical care services for chronic diseases and their medication adherence during COVID-19 in Saudi Arabia.
    Lucca JM; Kurdi S; Albaqshi B; Joseph R
    Int J Pharm Pract; 2022 May; 30(2):136-142. PubMed ID: 35294010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the COVID-19 pandemic on medication adherence: In the case of antiseizure medications, A scoping review.
    Menon S; Sander JW
    Seizure; 2021 Dec; 93():81-87. PubMed ID: 34717290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic Review.
    Olmastroni E; Galimberti F; Tragni E; Catapano AL; Casula M
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36900831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.
    Zheng SQ; Yang L; Zhou PX; Li HB; Liu F; Zhao RS
    Res Social Adm Pharm; 2021 Jan; 17(1):1819-1824. PubMed ID: 32249102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
    Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of COVID-19 on the care of people living with noncommunicable diseases in low- and middle-income countries: an online survey of physicians and pharmacists in nine countries.
    Bullen C; McCormack J; Calder A; Parag V; Subramaniam K; Majumdar A; Huang PH; Devi R; El Bizri L; Goodyear-Smith F
    Prim Health Care Res Dev; 2021 Jun; 22():e30. PubMed ID: 34120672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Older adults with non-communicable chronic conditions and their health care access amid COVID-19 pandemic in Bangladesh: Findings from a cross-sectional study.
    Mistry SK; Ali ARMM; Yadav UN; Ghimire S; Hossain MB; Das Shuvo S; Saha M; Sarwar S; Nirob MMH; Sekaran VC; Harris MF
    PLoS One; 2021; 16(7):e0255534. PubMed ID: 34324556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health, psychosocial, and economic impacts of the COVID-19 pandemic on people with chronic conditions in India: a mixed methods study.
    Singh K; Kondal D; Mohan S; Jaganathan S; Deepa M; Venkateshmurthy NS; Jarhyan P; Anjana RM; Narayan KMV; Mohan V; Tandon N; Ali MK; Prabhakaran D; Eggleston K
    BMC Public Health; 2021 Apr; 21(1):685. PubMed ID: 33832478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leveraging Telemedicine for Chronic Disease Management in Low- and Middle-Income Countries During Covid-19.
    Hoffer-Hawlik MA; Moran AE; Burka D; Kaur P; Cai J; Frieden TR; Gupta R
    Glob Heart; 2020 Sep; 15(1):63. PubMed ID: 33150128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A snapshot of the global policies and practices of medicine use reviews by community pharmacist in chronic diseases: A narrative review.
    Mubarak N; Raja SA; Khan TM; Zin CS
    J Pak Med Assoc; 2021 Mar; 71(3):950-965. PubMed ID: 34057955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global Perspectives on Improving Chronic Disease Prevention and Management in Diverse Settings.
    Airhihenbuwa CO; Tseng TS; Sutton VD; Price L
    Prev Chronic Dis; 2021 Apr; 18():E33. PubMed ID: 33830913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing medicines in the time of COVID-19: implications for community-dwelling people with dementia.
    Barry HE; Hughes CM
    Int J Clin Pharm; 2021 Feb; 43(1):275-279. PubMed ID: 32803555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia.
    Parajuli DR; Khanal S; Wechkunanukul KH; Ghimire S; Poudel A
    Res Social Adm Pharm; 2022 Aug; 18(8):3453-3462. PubMed ID: 34810136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?
    Oh KB; Doherty TM; Vetter V; Bonanni P
    Expert Rev Vaccines; 2022 Nov; 21(11):1541-1553. PubMed ID: 36039786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.